KAYLA GEAREN: Open Payments
NPI 1396513610 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 9 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $85 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Insulet Corporation | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $18 |
| Verona Pharma, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Averitas Pharma Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: CAPLYTA, Omnipod, JOURNAVX, GVOKE HYPOPEN, Ohtuvayre, MOUNJARO, QUTENZA, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
